MIF and atherosclerosis: In addition, CXCR4 could be involved in the development of atherosclerosis by regulating macrophage migration inhibitor (MIF) and macrophage formation, thereby affecting leukocyte recruitment and inflammatory responses, suggesting that CXCR4 may be a therapeutic target for atherosclerosis.33